click below
click below
Normal Size Small Size show me how
PHO 3
| Generic | Brand | Pharmacologic Category | Common Indication | Key Side Effects | Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|
| methotrexate (PO) | Trexall | Antimetabolite (folic acid antagonist) | RA, Crohn's Disease, psoriasis, various hematologic and solid tumors | stomatitis, N/V/D, thrombocytopenia, leukopenia, increased hepatic transaminases, pulmonary fibrosis | serious toxic rxns; may cause fetal death or abnormalities; severe bone marrow suppression, anemia and toxicity w/ NSAIDS; cause hepatotoxicity, induce lung disease, pneumonitis | taken w/ folic acid may reduce hematologic, GI, and hepatic side effects |
| cisplatin (IV, IT, IP) | Kemoplat | Antineoplastic agent, platinum-based compound | Bladder, Ovarian, and Testicular cancer | bone marrow suppression, N/V, nephro/neuro/oto-toxicity | myelosuppresion, renal toxicity, neuropathy | --- |
| doxorubicin (IV) | Adriamycin | Antineoplastic agent, anthracycline | Adjuvant therapy for breast cancer | cardiomyopathy, alopecia, N/V, bone marrow suppression | secondary malignancies; extravasation can result in local tissue injury and necrosis | may cause red discoloration of body fluids |
| pembrolizumab (IV) | Keytruda | Antineoplastic agent, monoclonal antibody | Various cancers | peripheral edema, pruritis, endocrine/metabolic abnormalities, N/V/D, constipation, hematuria, anemia, AST/ALT elevation, fatigue, MSK pain, increased SCr, dyspnea | --- | --- |
| anastrozole (PO) | Arimedex | Aromatase inhibitor | Hormone receptor-positive breast cancer | fatigue, rash, flushing, hot flashes, arthralgia, N/V, HTN, peripheral edema, osteoporosisfatigue, rash, flushing, hot flashes, arthralgia, N/V, HTN, peripheral edema, osteoporosis | --- | cardiovascular side effects, fetal toxicity |
| tamoxifen (PO) | Soltamox | Selective estrogen receptor modulator (SERM) | Hormone receptor-positive breast cancer | hot flashes, vaginal discharge, decreased bone density | risk of uterine or endometrial cancer and thrombolytic events | contraception use in premenopausal females (teratogenic); DNU w/ warfarin or hx DVT/PE |